نتائج البحث - "Compston, D. A."

1

Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?

المؤلفون: Cerqueira, João José, Compston, D. Alastair S., Geraldes, Ruth, Rosa, Mario M., Schmierer, Klaus, Thompson, Alan, Tinelli, Michela, Palace, Jacqueline

المساهمون: Universidade do Minho

مصطلحات موضوعية: multiple sclerosis, Science & Technology

وصف الملف: application/pdf

Relation: 0022-3050; 1468-330X; 29618493

الاتاحة: http://hdl.handle.net/1822/57801

View record in RCAAP

2

Academic Journal

Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation

المؤلفون: Sajic, Marija, Hunt, David P.J., Lee, Woojin, Compston, D. Alastair S., Schweimer, Judith V., Gregson, Norman A., Chandran, Siddharthan, Smith, Kenneth J.

المساهمون: University of St Andrews. School of Psychology and Neuroscience

مصطلحات موضوعية: RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry, Biochemistry, Genetics and Molecular Biology(all), Agricultural and Biological Sciences(all), SDG 3 - Good Health and Well-being, RC0321

وصف الملف: application/pdf

Relation: PLoS ONE; Sajic , M , Hunt , D P J , Lee , W , Compston , D A S , Schweimer , J V , Gregson , N A , Chandran , S & Smith , K J 2012 , ' Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation ' , PLoS ONE , vol. 7 , no. 2 , e30708 . https://doi.org/10.1371/journal.pone.0030708; PURE: 275054070; PURE UUID: 065f362b-327c-4698-b4d8-30f4364440a0; Scopus: 84863171061; PubMed: 22359549; ORCID: /0000-0002-5968-3534/work/108119023; http://hdl.handle.net/10023/23592; https://doi.org/10.1371/journal.pone.0030708

الاتاحة: http://hdl.handle.net/10023/23592
https://doi.org/10.1371/journal.pone.0030708

View record in BASE

Full Text Finder

3

Academic Journal

Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial.

المؤلفون: Coles, Alasdair J, Arnold, Douglas L, Bass, Ann D, Boster, Aaron L, Compston, D Alastair S, Fernández, Óscar, Havrdová, Eva Kubala, Nakamura, Kunio, Traboulsee, Anthony, Ziemssen, Tjalf, Jacobs, Alan, Margolin, David H, Huang, Xiaobi, Daizadeh, Nadia, Chirieac, Madalina C, Selmaj, Krzysztof W

المصدر: essn: 1756-2864 ; nlmid: 101480242

مصطلحات موضوعية: CD52, MRI, alemtuzumab, brain volume, disability, disease activity, efficacy, extension, multiple sclerosis, relapse, safety

وصف الملف: application/pdf

Relation: https://www.repository.cam.ac.uk/handle/1810/324468

الاتاحة: https://www.repository.cam.ac.uk/handle/1810/324468
https://doi.org/10.17863/CAM.71920

View record in BASE

4

Academic Journal

Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years

المؤلفون: Oh, Jiwon, Achiron, Anat, Celius, Elisabeth Gulowsen, Chambers, Christina, Derwenskus, Joy, Devonshire, Virginia, Hellwig, K, Hutton, George J., McCombe, Pamela, Moore, Marie, Rog, David, Schneider, Jean-Raphael, Simm, Renata Faria, Sousa, Livia, Vincent, Stephen G., Chung, Luke, Daizadeh, Nadia, Mitchell, Colin, Compston, D. Alastair S.

المصدر: 2211-0348.

Relation: http://urn.nb.no/URN:NBN:no-87900; Oh, Jiwon Achiron, Anat Celius, Elisabeth Gulowsen Chambers, Christina Derwenskus, Joy Devonshire, Virginia Hellwig, K Hutton, George J. McCombe, Pamela Moore, Marie Rog, David Schneider, Jean-Raphael Simm, Renata Faria Sousa, Livia Vincent, Stephen G. Chung, Luke Daizadeh, Nadia Mitchell, Colin Compston, D. Alastair S. . Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years. Multiple Sclerosis and Related Disorders. 2020, 43; http://hdl.handle.net/10852/85205; 1890575; info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Multiple Sclerosis and Related Disorders&rft.volume=43&rft.spage=&rft.date=2020; Multiple Sclerosis and Related Disorders; 43; https://doi.org/10.1016/j.msard.2020.102146; URN:NBN:no-87900; Fulltext https://www.duo.uio.no/bitstream/handle/10852/85205/2/Pregnancy%2Boutcomes%2Band%2Bpostpartum%2Brelapse%2Brates%2Bin%2Bwomen%2Bwith%2BRRMS.pdf

الاتاحة: http://hdl.handle.net/10852/85205
http://urn.nb.no/URN:NBN:no-87900
https://doi.org/10.1016/j.msard.2020.102146

View record in BASE

5

Academic Journal

Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial

المؤلفون: Coles, Alasdair J., Arnold, Douglas L., Bass, Ann D., Boster, Aaron L., Compston, D. Alastair S., Fernández, Óscar, Havrdová, Eva Kubala, Nakamura, Kunio, Traboulsee, Anthony, Ziemssen, Tjalf, Jacobs, Alan, Margolin, David H., Huang, Xiaobi, Daizadeh, Nadia, Chirieac, Madalina C., Selmaj, Krzysztof W.

المساهمون: Bayer HealthCare Pharmaceuticals, Sanofi

المصدر: Therapeutic Advances in Neurological Disorders ; volume 14, page 175628642098213 ; ISSN 1756-2864 1756-2864

الاتاحة: http://dx.doi.org/10.1177/1756286420982134
http://journals.sagepub.com/doi/pdf/10.1177/1756286420982134
http://journals.sagepub.com/doi/full-xml/10.1177/1756286420982134

View record in BASE

6

Academic Journal

Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223

المؤلفون: Steingo, Brian, Al Malik, Yaser, Bass, Ann D., Berkovich, Regina, Carraro, Matthew, Fernández, Óscar, Ionete, Carolina, Massacesi, Luca, Meuth, Sven G., Mitsikostas, Dimos D., Pardo, Gabriel, Simm, Renata Faria, Traboulsee, Anthony, Choudhry, Zia, Daizadeh, Nadia, Compston, D. Alastair S.

مصطلحات موضوعية: Original Communication, Alemtuzumab, Multiple sclerosis, Disease-modifying therapy, Efficacy, Safety, Long-term

وصف الملف: application/pdf; text/xml; application/zip

Relation: https://www.repository.cam.ac.uk/handle/1810/311830

الاتاحة: https://doi.org/10.17863/CAM.58921
https://www.repository.cam.ac.uk/handle/1810/311830

View record in BASE

7

Academic Journal

THUR 196 Pregnancy outcomes in alemtuzumab-treated rrms patients

المؤلفون: David, Rog, Jiwon, Oh, Christina, Chambers, Kerstin, Hellwig, Pamela, McCombe, Luke, Chung, Nadia, Daizadeh, S, Compston D Alastair

مصطلحات موضوعية: Poster session

وصف الملف: text/html

Relation: http://jnnp.bmj.com/cgi/content/short/89/10/A28-c; http://dx.doi.org/10.1136/jnnp-2018-ABN.98

الاتاحة: http://jnnp.bmj.com/cgi/content/short/89/10/A28-c
https://doi.org/10.1136/jnnp-2018-ABN.98

View record in BASE

8

Academic Journal

Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?

المؤلفون: Cerqueira, João J, Compston, D Alastair S, Geraldes, Ruth, Rosa, Mario M, Schmierer, Klaus, Thompson, Alan, Tinelli, Michela, Palace, Jacqueline

مصطلحات موضوعية: Multiple sclerosis

وصف الملف: text/html

Relation: http://jnnp.bmj.com/cgi/content/short/89/8/844; http://dx.doi.org/10.1136/jnnp-2017-317509

الاتاحة: http://jnnp.bmj.com/cgi/content/short/89/8/844
https://doi.org/10.1136/jnnp-2017-317509

View record in BASE

9

Academic Journal

Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy

المصدر: Havrdova, Eva; Arnold, Douglas L; Cohen, Jeffrey A; Hartung, Hans-Peter; Fox, Edward J; Giovannoni, Gavin; Schippling, Sven; Selmaj, Krzysztof W; Traboulsee, Anthony; Compston, D Alastair S; Margolin, David H; Thangavelu, Karthinathan; Rodriguez, Claudio E; Jody, Darlene; Hogan, Richard J; Xenopoulos, Panos; Panzara, Michael A; Coles, Alasdair J; CARE-MS I; CAMMS03409 Investigators (2017). Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. Neurology, 89(11):1107-1116.

مصطلحات موضوعية: Clinic for Neurology, 610 Medicine & health

وصف الملف: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/141425/1/1107.full.pdf; info:pmid/28835401; urn:issn:0028-3878

الاتاحة: https://www.zora.uzh.ch/id/eprint/141425/
https://www.zora.uzh.ch/id/eprint/141425/1/1107.full.pdf
https://doi.org/10.1212/WNL.0000000000004313

View record in BASE

10

Academic Journal

Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings

المصدر: Coles, Alasdair J; Cohen, Jeffrey A; Fox, Edward J; Giovannoni, Gavin; Hartung, Hans-Peter; Havrdova, Eva; Schippling, Sven; Selmaj, Krzysztof W; Traboulsee, Anthony; Compston, D Alastair S; Margolin, David H; Thangavelu, Karthinathan; Chirieac, Madalina C; Jody, Darlene; Xenopoulos, Panos; Hogan, Richard J; Panzara, Michael A; Arnold, Douglas L; CARE-MS II; CAMMS03409 Investigators (2017). Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings. Neurology, 89(11):1117-1126.

مصطلحات موضوعية: Clinic for Neurology, 610 Medicine & health

وصف الملف: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/141423/1/1117.full.pdf; info:pmid/28835403; urn:issn:0028-3878

الاتاحة: https://www.zora.uzh.ch/id/eprint/141423/
https://www.zora.uzh.ch/id/eprint/141423/1/1117.full.pdf
https://doi.org/10.1212/WNL.0000000000004354

View record in BASE